BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2022 12:11:23 AM | Browse: 328 | Download: 737
 |
Received |
|
2021-03-25 19:12 |
|
Peer-Review Started |
|
2021-03-25 19:18 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-16 02:05 |
|
Revised |
|
2021-06-28 21:33 |
|
Second Decision |
|
2021-12-08 07:01 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-10 03:41 |
|
Articles in Press |
|
2021-12-10 03:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-31 06:40 |
|
Publish the Manuscript Online |
|
2022-01-11 00:11 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nikolaos Charalampakis, Sergios Tsakatikas, Dimitrios Schizas, Stylianos Kykalos, Maria Tolia, Rodanthi Fioretzaki, Georgios Papageorgiou, Ioannis Katsaros, Ahmed Adel Fouad Abdelhakeem, Matheus Sewastjanow-Silva, Jane E Rogers and Jaffer A Ajani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nikolaos Charalampakis, MD, PhD, Attending Doctor, Department of Medical Oncology, Metaxa Cancer Hospital of Piraeus, Mpotasi 51, Piraeus 18537, Greece. nick301178@yahoo.com |
| Key Words |
Gastric cancer; Gastroesophageal junction cancer; Trimodality treatment; Chemoradiotherapy; Surgery; Immunotherapy |
| Core Tip |
Trimodality treatment combining chemotherapy, radiation and surgery is an effective management of locally advanced gastric and gastroesophageal cancers, although the extent of benefit remains to be answered in future clinical trials. Addition of newer therapeutic agents, such as immune checkpoint inhibitors may further enhance the curative potential of this approach. |
| Publish Date |
2022-01-11 00:11 |
| Citation |
Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives. World J Gastrointest Oncol 2022; 14(1): 181-202 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i1/181.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i1.181 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
